1. Home
  2. VIAV vs AAPG Comparison

VIAV vs AAPG Comparison

Compare VIAV & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • AAPG
  • Stock Information
  • Founded
  • VIAV 1923
  • AAPG 2009
  • Country
  • VIAV United States
  • AAPG China
  • Employees
  • VIAV N/A
  • AAPG N/A
  • Industry
  • VIAV Semiconductors
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIAV Technology
  • AAPG Health Care
  • Exchange
  • VIAV Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • VIAV 2.1B
  • AAPG 2.2B
  • IPO Year
  • VIAV 1993
  • AAPG 2025
  • Fundamental
  • Price
  • VIAV $9.40
  • AAPG $37.38
  • Analyst Decision
  • VIAV Buy
  • AAPG Buy
  • Analyst Count
  • VIAV 8
  • AAPG 1
  • Target Price
  • VIAV $12.69
  • AAPG N/A
  • AVG Volume (30 Days)
  • VIAV 2.0M
  • AAPG 14.6K
  • Earning Date
  • VIAV 08-07-2025
  • AAPG 08-06-2025
  • Dividend Yield
  • VIAV N/A
  • AAPG N/A
  • EPS Growth
  • VIAV N/A
  • AAPG N/A
  • EPS
  • VIAV 0.02
  • AAPG N/A
  • Revenue
  • VIAV $1,045,800,000.00
  • AAPG $134,352,180.00
  • Revenue This Year
  • VIAV $10.06
  • AAPG N/A
  • Revenue Next Year
  • VIAV $7.08
  • AAPG $389.09
  • P/E Ratio
  • VIAV $411.46
  • AAPG N/A
  • Revenue Growth
  • VIAV 3.34
  • AAPG 341.77
  • 52 Week Low
  • VIAV $6.60
  • AAPG $16.50
  • 52 Week High
  • VIAV $12.91
  • AAPG $37.95
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 50.27
  • AAPG N/A
  • Support Level
  • VIAV $9.14
  • AAPG N/A
  • Resistance Level
  • VIAV $9.64
  • AAPG N/A
  • Average True Range (ATR)
  • VIAV 0.23
  • AAPG 0.00
  • MACD
  • VIAV 0.03
  • AAPG 0.00
  • Stochastic Oscillator
  • VIAV 65.71
  • AAPG 0.00

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: